Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Journal of Clinical Investigation2018Vol. 128(2), pp. 668–681
Citations Over TimeTop 1% of 2018 papers
Laura Rivino, Nina Le Bert, Upkar S. Gill, Kamini Kunasegaran, Yang Cheng, Damien Tan, Étienne Becht, Navjyot Hansi, Graham R. Foster, Tung‐Hung Su, Tai‐Chung Tseng, Seng Gee Lim, Jia‐Horng Kao, Evan W. Newell, Patrick Kennedy, Antonio Bertoletti
Abstract
This work was funded by a Singapore Translational Research Investigator Award (NMRC/STaR/013/2012), the Eradication of HBV TCR Program (NMRC/TCR/014-NUHS/2015), the Singapore Immunology Network, the Wellcome Trust (107389/Z/15/Z), and a Barts and The London Charity (723/1795) grant.
Related Papers
- → Long term virological follow up of Hepatitis C (VHC) monoinfected patients who achieved end of treatment response (ETR)(2010)
- Research progress of antiviral therapy on chronic hepatitis C(2013)
- [Current issues in antiviral therapy of chronic hepatitis B and C].(2010)
- [A report from the second symposium on the hots and difficult points during antiviral therapy for chronic hepatitis B].(2011)
- → Pharmaco-economical analysis and its applying to economical efficacy evaluation of different antiviral therapy schemes of chronic hepatitis c(2006)